TY - JOUR
T1 - An overview of bioinformatics methods for analyzing autism spectrum disorders
AU - Nakashima, Shogo
AU - Nacher, Jose C.
AU - Song, Jiangning
AU - Akutsu, Tatsuya
PY - 2019/11/27
Y1 - 2019/11/27
N2 - Autism Spectrum Disorders (ASD) are a group of neurodevelopmental disorders and are well recognized to be biologically heterogeneous in which various factors are associated, including genetic, metabolic, and environmental ones. Despite its high prevalence, only a few drugs have been approved for the treatment of ASD. Therefore, extensive studies have been conducted to identify ASD risk genes and novel drug targets. Since many genes and many other factors are associated with ASD, various bioinformatics methods have also been developed for the analysis of ASD. In this paper, we review bioinformatics methods for analyzing ASD data with the focus on computational aspects. We classify existing methods into two categories: (i) methods based on genomic variants and gene expression data, and (ii) methods using biological networks, which include gene co-expression networks and protein-protein interaction networks. Next, for each method, we provide an overall flow and elaborate on the computational techniques used. We also briefly review other approaches and discuss possible future directions and strategies for developing bioinformatics approaches to analyze ASD.
AB - Autism Spectrum Disorders (ASD) are a group of neurodevelopmental disorders and are well recognized to be biologically heterogeneous in which various factors are associated, including genetic, metabolic, and environmental ones. Despite its high prevalence, only a few drugs have been approved for the treatment of ASD. Therefore, extensive studies have been conducted to identify ASD risk genes and novel drug targets. Since many genes and many other factors are associated with ASD, various bioinformatics methods have also been developed for the analysis of ASD. In this paper, we review bioinformatics methods for analyzing ASD data with the focus on computational aspects. We classify existing methods into two categories: (i) methods based on genomic variants and gene expression data, and (ii) methods using biological networks, which include gene co-expression networks and protein-protein interaction networks. Next, for each method, we provide an overall flow and elaborate on the computational techniques used. We also briefly review other approaches and discuss possible future directions and strategies for developing bioinformatics approaches to analyze ASD.
KW - ASD
KW - Autism
KW - Bioinformatics
KW - Bioinformatics approaches
KW - Genomic variants
KW - Neurodevelopmental disorders
UR - http://www.scopus.com/inward/record.url?scp=85078269635&partnerID=8YFLogxK
U2 - 10.2174/1381612825666191111154837
DO - 10.2174/1381612825666191111154837
M3 - Review Article
C2 - 31713477
AN - SCOPUS:85078269635
SN - 1381-6128
VL - 25
SP - 4552
EP - 4559
JO - Current Pharmaceutical Design
JF - Current Pharmaceutical Design
IS - 43
ER -